Medicating Kids: Pediatric Mental Health Policy and the Tipping Point for ADHD and Stimulants

Journal of Policy History

Volumn 20, Issue 3, 2008, Pages 309-343

  Mayes, Rick ^a   Erkulwater, Jennifer ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956190950     PISSN: 08980306     EISSN: 15284190     Source Type: Journal    
DOI: 10.1353/jph.0.0018     Document Type: Article

References (162)

1. M. Wolraich, “Attention Deficit Hyperactivity Disorder: The Most Studied and Yet the Most Controversial Diagnosis,” Mental Retardation and Developmental Disabilities Research Reviews 5 (1999): 163-68.
2. J. Williams, K. Klinepeter, G. Palmes, A. Pulley, and F. Foy, “Diagnosis and Treatment of Behavioral Health Disorders in Pediatric Practice,” Pediatrics 114 (September 2004): 601-6.
3. S. Visser, C. Lesesne, and R. Perou, “National Estimates and Factors Associated with Medication Treatment for Childhood Attention-Deficit/Hyperactivity Disorder,” Pediatrics 119 (February 2007, suppl.): S99–S106
4. Centers for Disease Control and Prevention, “Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder,” MMWR. Morbidity and Mortality Weekly Report 54 (2 September 2005): 842–47.
5. M. Rappley, “Attention-Deficit Hyperactivity Disorder,” New England Journal of Medicine 352 (13 January 2005): 165–73
6. S. Zuvekas, B. Vitiello, and G. Norquist, “Recent Trends in Stimulant Medication Use among U.S. Children,” American Journal of Psychiatry 163 (May 2006): 579-85.
7. V. Bhatara, M. Feil, K. Hoagwood, B. Vitiello, and B. Zima, “National Trends in Concomitant Psychotropic Medication with Stimulants in Pediatric Visits: Practice versus Knowledge,” Journal of Attention Disorders 7 (May 2004): 217-26
8. L. Robison, D. Sclar, and T. Skaer, “Datapoints: Trends in adhd and Stimulant Use among Adults, 1995-2002,” Psychiatric Services 56 (December 2005): 1497
9. C. Thomas, P. Conrad, R. Casler, and E. Goodman, “Trends in the Use of Psychotropic Medications among Adolescents, 1994 to 2001,” Psychiatric Services 57 (January 2006): 63-69
10. M. Olfson, M. Gameroff, S. Marcus, and P. Jensen, “National Trends in the Treatment of Attention Deficit Hyperactivity Disorder,” American Journal of Psychiatry 160 (June 2003): 1071-77.
11. M. Eberstadt, “Why Ritalin Rules,” Policy Review 94 (April-May 1999): 24-44.
12. R. Chiarello and J. Cole, “The Use of Stimulants in General Psychiatry: A Reconsideration,” Archives of General Psychiatry 44 (March 1987): 286-95.
13. C. Bradley, “The Behavior of Children Receiving Benzedrine,” American Journal of Psychiatry 94 (November 1937): 577-78.
14. R. Barkley, Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (New York, 1990), 3–38.
15. R. Maynard, “Omaha Pupils Given ‘Behavior Drugs,’” Washington Post, 29 June 1970, 1.
16. J. Swanson, M. Lerner, and L. Williams, “More Frequent Diagnosis of Attention- Deficit Hyperactivity Disorder,” New England Journal of Medicine 333 (5 October 1995): 944.
17. H. Schneider and D. Eisenberg, “Who Receives a Diagnosis of Attention-Deficit/ Hyperactivity Disorder in the United States Elementary School Population?” Pediatrics 117 (April 2006): 601-9
18. T. Spencer, J. Biederman, and E. Mick, “Attention-Deficit/Hyperactivity Disorder: Diagnosis, Lifespan, Comorbidities, and Neurobiology,” Ambulatory Pediatrics 7 (January-February 2007): 73-81
19. Zuvekas, Vitiello, and Norquist, “Recent Trends in Stimulant Medication among U.S. Children,” 579–85.
20. R. Scotch, “Politics and Policy in the History of the Disability Rights Movement,” Milbank Quarterly 67 (1989): 380-400
21. R. Sommer, “Family Advocacy and the Mental Health System: The Recent Rise of the Alliance for the Mentally Ill,” Psychiatric Quarterly 61 (Fall 1990): 205-21
22. N. Tomes, “The Patient as a Policy Factor: A Historical Case Study of the Consumer/Survivor Movement in Mental Health,” Health Affairs 25 (May-June 2006): 720-29
23. A. McLean, “Empowerment and the Psychiatric Consumer/Ex-Patient Movement in the United States: Contradictions, Crisis and Change,” Social Science & Medicine 40 (April 1995): 1053-71
24. A. Hatfield, “The National Alliance for the Mentally Ill: A Decade Later,” Community Mental Health Journal 27 (April 1991): 95-103
25. M. Minow and R. Weissbourd, “Social Movements for Children,” Daedalus 122 (Winter 1993): 1-29
26. D. Pfeiffer, “Overview of the Disability Movement: History, Legislative Record, and Political Implications,” Policy Studies Journal 21 (December 1993): 724-34.
27. J. Perrin, K. Kuhlthau, T. McLaughlin, S. Ettner, and S. Gortmaker, “Changing Patterns of Conditions among Children Receiving Supplemental Security Income Disability Benefits,” Archives of Pediatric & Adolescent Medicine 153 (January 1999): 80–84
28. R. Reid, J. Maag, and S. Vasa, “Attention Deficit Hyperactivity Disorder as a Disability Category: A Critique,” Exceptional Children 60 (December 1993-January 1994): 198–214.
29. R. Bayer and R. Spitzer, “Neurosis, Psychodynamics, and dsm-iii,” Archives of General Psychiatry 42 (February 1985): 188.
30. See R. Michels and P. Marzuk, “Progress in Psychiatry,” New England Journal of Medicine 329 (19 August, 26 August 1993): 552–60, 628-38.
31. See R. Mayes and A. Horwitz, “dsm-iii and the Revolution in the Classification of Mental Illness,” Journal of the History of the Behavioral Sciences 41 (Summer 2005): 249-67.
32. See P. Brown, “Diagnostic conflict and Contradiction in Psychiatry,” Journal of Health and Social Behavior 28 (March 1987): 37-50.
33. See D. Goodwin and S. Guze, Psychiatric Diagnosis, 5th ed. (New York, 1996).
34. See L. Rogler, “Making Sense of Historical Changes in the Diagnostic and Statistical Manual of Mental Disorders: Five Propositions,” Journal of Health and Social Behavior 39 (March 1997): 9-20.
35. SeeR. Frank and S. Glied, Better but Not Well: Mental Health Policy in the U.S. Since 1950 (Baltimore, 2006).
36. See A. Frances, H. Pincus, T. Widiger, W. Davis, and M. First, “dsm-iv: Work in Progress,” American Journal of Psychiatry 147 (November 1990): 1439-48.
37. See A. Horwitz, Creating Mental Illness (Chicago, 1992)
38. G. Greenberg, “Manufacturing Depression: A Journey into the Economy of Melancholy,” Harpers, May 2007, 35–46.
39. See J. Silk, S. Nath, L. Siegel, and P. Kendall, “Conceptualizing Mental Disorders in Children: Where Have We Been and Where Are We Going?” Development and Psychopathology 12 (2000): 713-35.
40. See N. Hamm, “The Politics of Empiricism: Research Recommendations of the Joint Commission on Mental Health in Children,” American Psychologist 29 (January 1974): 9-13
41. W. Taylor, “Developmental Theory: Unsolved Problem for Child Psychiatry,” American Journal of Orthopsychiatry 41 (July 1971): 557-65
42. W. Goodrich, “Changes in Child Psychiatry Training Required by Developmental-Adaptive Theory,” Journal of Nervous and Mental Disease 154 (March 1972): 213-20
43. C. Ramey, “Children and Public Policy: A Role for Psychologists,” American Psychologist 29 (January 1974): 14-18
44. J. Dusek, “Implications of Development Theory for Child Mental Health,” American Psychologist 29 (January 1974): 19-24
45. J. Segal and H. Yahraes, “Protecting Children's Mental Health,” Children Today 7 (September-October 1978): 23-25
46. L. Wright, “Health Care Psychology: Prospects for the Well-Being of Children,” American Psychologist 34 (October 1979): 1001-1006
47. A. Marks and M. Cohen, “Health Screening and Assessment of Adolescents,” Pediatric Annals 7 (September 1978): 596-604
48. M. Laufer, “Which Adolescents Must Be Helped and by Whom?” Journal of Adolescence 3 (December 1980): 265-72
49. A. Marks, “Aspects of Biosocial Screening and Health Maintenance in Adolescents,” Pediatric Clinics of North America 27 (February 1980): 153-61.
50. See C. Kopp and J. Krakow, “The Developmentalist and the Study of Biological Risk: A View of the Past with an Eye to the Future,” Child Development 54 (October 1983): 1086-1108.
51. See N. Weiss, “Mother, the Invention of Necessity: Dr. Benjamin Spock's Baby and Child Care,” American Quarterly 29 (1977): 519-46.
52. See S. Rosenbaum and P. Wise, “Crossing the Medicaid-Private Insurance Divide: The Case of epsdt,” Health Affairs 26 (March-April 2007): 382-93
53. A. Foltz, “The Development of Ambiguous Federal Policy: Early and Periodic Screening, Diagnosis, and Treatment (epsdt),” Milbank Memorial Fund Quarterly 53 (Winter 1975): 35-64.
54. See P. Irwin and R. Conroy-Hughes, “epsdt Impact on Health Status,” Health Care Financing Review 2 (Spring 1981): 25-39.
55. See J. Richmond, “Disadvantaged Children: What Have They Compelled Us to Learn?” Yale Journal of Biology & Medicine 43 (December 1970): 127-44.
56. Silk, Nath, Siegel, and Kendall, “Conceptualizing Mental Disorders in Children: Where Have We Been and Where Are We Going?” 720.
57. See L. Shear, “From Competition to Complementarity: Legal Issues and Their Clinical Implications in Custody,” Child and Adolescent Psychiatric Clinics of North America 7 (April 1998): vi-viii, 311-34
58. See F. Blau, “Trends in the Well-Being of American Women, 1970-1995,” Journal of Economic Literature 36 (March 1998): 112-65.
59. See J. Kendall, M. Leo, N. Perrin, and D. Hatton, “Modeling adhd Child and Family Relationships,” Western Journal of Nursing Research 27 (2005): 500-518
60. J. Morgan, D. Robinson, and J. Aldridge, “Parenting Stress and Externalizing Child Behavior,” Child & Family Social Work 7 (August 2002): 219-25.
61. See E. Kitagawa, “New Life-Styles: Marriage Patterns, Living Arrangements, and Fertility Outside of Marriage,” The Annals of the American Academy of Political and Social Science 453 (1981): 1-27
62. A. Th ornton and D. Freedman, “The Changing American Family,” Population Bulletin 38 (October 1983): 1-44.
63. See B. Weiner, “An Overview of Child Custody Laws,” Hospital & Community Psychiatry 36 (August 1985): 838-43.
64. See J. Kelly, “Children's Adjustment in conflicted Marriage and Divorce: A Decade Review of Research,” Journal of the American Academy of Child & Adolescent Psychiatry 39 (August 2000): 963-73.
65. See R. Doan and T. Petti, “Clinical and Demographic Characteristics of Child and Adolescent Partial Hospital Patients,” Journal of the American Academy of Child & Adolescent Psychiatry 28 (January 1989): 66-69
66. J. Wallen and H. Pincus, “Care of Children with Psychiatric Disorders at Community Hospitals,” Hospital & Community Psychiatry 39 (February 1988): 167-72
67. K. Pottick, D. McAlpine, and R. Andelman, “Changing Patterns of Psychiatric Inpatient Care for Children and Adolescents in General Hospitals, 1988-1995,” American Journal of Psychiatry 157 (August 2000): 1267-73
68. B. Case, M. Olfson, S. Marcus, and C. Siegel, “Trends in the Inpatient Mental Health Treatment of Children and Adolescents in U.S. Community Hospitals between 1990 and 2000,” Archives of General Psychiatry 64 (January 2007): 89-96.
69. See M. Olfson and G. Klerman, “Trends in the Prescription of Psychotropic Medications: The Role of Physician Specialty,” Medical Care 31 (1993): 559-64
70. D. Safer and J. Krager, “A Survey of Medication Treatment for Hyperactive/Inattentive Students,” Journal of the American Medical Association 260 (21 October 1988): 2256–58.
71. See D. Safer and J. Krager, “Effect of a Media Blitz and a Threatened Lawsuit on Stimulant Treatment,” Journal of the American Medical Association 268 (26 August 1992): 1004–1007
72. L. Williams, “Parents and Doctors Fear Growing Misuse of Drug Used to Treat Hyperactive Kids,” Wall Street Journal, 15 January 1988, 1
73. D. Moss, “Ritalin under Fire,” ABA Journal 74 (1 November 1988): 19.
74. See D. Rissmiller and J. Rissmiller, “Evolution of the Antipsychiatry Movement into Mental Health Consumerism,” Psychiatric Services 57 (June 2006): 863-66.
75. See E. Ouellette, “Legal Issues in the Treatment of Children with Attention Deficit Disorder,” Journal of Child Neurology 6 (1991, suppl.): 569–75
76. R. Welke, “Litigation Involving Ritalin and the Hyperactive Child,” Detroit College Law Review (Spring 1999): 125–76.
77. K. McBurnett, B. Lahey, and L. Pfiffner, “Diagnosis of Attention Deficit Disorders in dsm-iv: Scientific Basis and Implications for Education,” Exceptional Children 60 (October-November 1993): 109.
78. See B. Lahey, R. Loeber, M. Stouthammer-Loeber, M. Christ, S. Green. M. Russo, P. Frick, and M. Dulcan, “Comparison of dsm-iii and dsm-iii-r Diagnoses for Prepubertal Children: Changes in Prevalence and Validity,” Journal of the American Academy of Child and Adolescent Psychiatry 29 (July 1990): 620-26.
79. See L. Diller, Running on Ritalin (New York, 1999), 130–31.
80. See N. Rojas and E. Chan, “Old and New Controversies in the Alternative Treatment of Attention-Deficit Hyperactivity Disorder,” Mental Retardation and Developmental Disabilities Research Reviews 11 (2005): 116-30.
81. See Swanson, Lerner, and Williams, “More Frequent Diagnosis of Attention Deficit-Hyperactivity Disorder,” 994
82. Diller, Running on Ritalin, 146–50
83. U.S. General Accounting Office, “Social Security: Rapid Rise in Children on ssi Disability Rolls Follows New Regulations,” GAO/HEHS-94-225 (Washington, D.C. September 1994).
84. See J. Zito, D. Safer, S. dosReis, L. Magder, J. Gardner, and D. Zarin, “Psychotherapeutic Medication Patterns for Youths with Attention-Deficit/Hyperactivity Disorder,” Archives of Pediatrics & Adolescent Medicine 153 (December 1999): 1257-65
85. Pincus, Tanielian, Marcus, Olfson, Zarin, Thompson, and Zito, “Prescribing Trends in Psychotropic Medications: Primary Care, Psychiatry, and Other Medical Specialties,” 526–31.
86. See P. Newacheck and W. Taylor, “Childhood Chronic Illness: Prevalence, Severity, and Impact,” American Journal of Public Health 82 (1992): 364-71.
87. See K. Kelleher, G. Childs, R. Wasserman, T. McInemy, P. Nutting, and W. Gardner, “Insurance Status and Recognition of Psychosocial Problems: A Report from PROS and ASPN,” Archives of Pediatric & Adolescent Medicine 151 (1998): 1109-15
88. K. Kelleher and M. Wolraich, “Diagnosing Psychosocial Problems,” Pediatrics 97 (1996): 899-901
89. K. Kelleher and S. Scholle, “Children with Chronic Medical Conditions II: Managed Care Opportunities and Th reats,” Ambulatory Child Health 1 (1995): 139-46
90. K. Kelleher, S. Scholle, H. Feldman, and D. Nace, “A Fork in the Road: Decision Time for Behavioral Pediatrics,” Journal of Developmental Behavioral Pediatrics 20 (1999): 181-86.
91. See K. Hoagwood, K. Kelleher, M. Feil, and D. Comer, “Treatment Services for Children with adhd: A National Perspective,” Journal of the American Academy of Child & Adolescent Psychiatry 39 (February 2000): 198-206.
92. See Cantwell, “Attention Deficit Disorder: A Review of the Past 10 Years,” 982–85.
93. K. Kelleher, T. McInerny, W. Gardner, G. Childs, and R. Wasserman, “Increasing Identifi cation of Psychosocial Problems: 1979-1996,” Pediatrics 105 (June 2000): 1313.
94. See C. Liu, A. Robin, S. Brenner, and J. Eastman, “Social Acceptability of Methylphenidate and Behavior Modifi cation for Treating Attention Deficit Hyperactivity Disorder,” Pediatrics 88 (September 1991): 560-65.
95. G. Kolata, “Researchers Say Brain Abnormality May Help to Explain Hyperactivity,” New York Times, 15 November 1990, B18.
96. A. Zametkin, T. Nordahl, M. Gross, A. King, W. Semple, J. Rumsey, S. Hamburger, and R. Cohen, “Cerebra Glucose Metabolism in Adults with Hyperactivity of Childhood Onset,” New England Journal of Medicine 323 (15 November 1990): 1361–66.
97. A. Zametkin and L. Liebenauer et aL. “Brain Metabolism in Teenagers with Attention-Deficit Hyperactivity Disorder,” Archives of General Psychiatry 50 (1993): 333-40
98. M. Ernst and L. Liebenauer et aL. “Reduced Brain Metabolism in Hyperactive Girls,” Journal of the American Academy of Child and Adolescent Psychiatry 33 (1994): 858-68
99. M. Ernst and R. Cohen et al. “Cerebral Glucose Metabolism in Adolescent Girls with Attention-Deficit/Hyperactivity Disorder,” Journal of the Academy of Child and Adolescent Psychiatry 36 (1997): 1399-1406.
100. J. Perrin, K. Kuhlthau, T. McLaughlin, S. Ettner, and S. Gortmaker, “Changing Patterns of Conditions among Children Receiving Supplemental Security Income Disability benefits,” Archives of Pediatrics & Adolescent Medicine 153 (January 1999): 80-84.
101. R. Reid, J. Maag, and S. Vasa, “Attention Deficit Hyperactivity Disorder as a Disability Category: A Critique,” Exceptional Children 60 (December-January 1993): 198-214.
102. L. Dubay and G. Kenney, “The Effects of Medicaid Expansions on Insurance Coverage of Children,” The Future of Children 6 (Spring 1996): 152-61
103. K. Kronebusch, “Medicaid for Children: Federal Mandates, Welfare Reform, and Policy Backsliding,” Health Affairs 20 (January-February 2001): 97-111.
104. A. Cuellar and S. Markowitz, “Medicaid Policy Changes in Mental Health Care and Their Effect on Mental Health Outcomes,” Health Economics, Policy & Law 2 (2007): 23-28.
105. N. Tomes, “The Patient as a Policy Factor: A Historical Case Study of the Consumer/Survivor Movement in Mental Health,” Health Affairs 25 (May-June 2006): 720-29.
106. J. Perrin, “Health Services Research for Children with Disabilities,” Milbank Quarterly 80 (2002): 303-24.
107. D. Safer and J. Krager, “The Increased Rate of Stimulant Treatment for Hyperactive/Inattentive Students in Secondary Schools,” Pediatrics 94 (October 1994): 462-64.
108. Chamberlain, “Psychiatric Survivors,” 4.
109. U.S. Senate, Committee on Labor and Public Welfare, Subcommittee on the Handicapped, “Education for All Handicapped Children, 1973#x2013;1974,” Hearings, 93rd Cong. 1st sess. 7 May 1973, 341.
110. See the accounts of this episode in J. Swanson, K. McBurnett, D. L. Christian, and T. Wigall, “Stimulant Medications and the Treatment of Children with adhd,” in T. Ollendick and R. Prinz, eds. Advances in Clinical Child Psychology (New York, 1995), 288–90, and
111. L. Diller, Running on Ritalin: A Physician Reflects on Children, Society, and Performance in a Pill (New York, 1998), 149–50.
112. U.S. House, Subcommittee on Select Education, Hearings on the Reauthorization, 352–55.
113. R. Reid, J. Maag, and S. Vasa, “Attention Deficit Hyperactivity Disorder as a Disability Category: A Critique,” Exceptional Children 60, no. 3 (December 1992-January 1993): 198–215, online document from Expanded Academic.
114. U.S. House Subcommittee on Select Education, Hearings on the Reauthorization of the EHA Discretionary Programs, 60, 78, 99.
115. See also Council for Exceptional Children, “The add Controversy: What Did cec Say?” Exceptional Children 60, no. 2 (October- November 1993): 181–82.
116. S. Aleman, Special Education for Children with Attention Deficit Disorders: Current Issues, Washington, D.C.: Congressional Research Service, 1991
117. L. Danielson, K. Henderson, and E. Schiller, “Education Policy--Educating Children with Attention Deficit Hyperactivity Disorder,” in P. Jenson and J. Cooper, eds. Attention Deficit Hyperactivity Disorder: State of the Science, Best Practices (Kingston, N.J. 2002), 26–32.
118. R. Appling, N. Jones, The Individuals with Disabilities Education Act (idea): Overview of Major Provisions, Congressional Research Service Report for Congress, 11 January 2002, 8.
119. Diller, Running on Ritalin, 150.
120. R. Davila, M. Williams, and J. MacDonald, Clarification of Policy to Address the Needs of Children with Attention Deficit Disorders within General and/or Special Education, Washington, D.C. September 16, 1991.
121. See M. Ozawa and B. Hong, “SSI for Children with Mental Disorders: Backgrounds and a Study of Participation,” Children and Youth Services Review 21 (June 1999): 437-62.
122. J. Mashaw, J. Perrin, and V. Reno, eds. Restructuring the ssi Disability Program for Children and Adolescents (Washington, D.C. 1996).
123. Erkulwater, Disability Rights and the American Social Safety Net, 132.
124. Zebley v. Bowen, Appeal from the U.S. District Court of the Eastern District of Pennsylvania, Civil Action No. 83-3314, to the U.S. Court of Appeals for the Third Circuit, amicus brief by the Mental Health Law Project on behalf of the American Academy of Child and Adolescent Psychiatry et al. 1988, 9-10, copy in authors' files. (The Mental Health Law Project was renamed the Bazelon Center for Mental Health in 1990).
125. Sullivan v. Zebley, 493 U.S. 521 (1990).
126. Mashaw, Perrin, and Reno, eds. Restructuring the ssi Disability Program, 27–29.
127. U.S. General Accounting Office, Social Security: New Functional Assessments for Children Raise Eligibility Questions, GAO/HEHS-95-66, 1995, fi g. 1, p 9–10.
128. Erkulwater, Disability Rights and the American Social Safety Net, 172–93.
129. U.S. General Accounting Office, Supplemental Security Income: Recent Growth in the Rolls Raises Fundamental Program Concerns, GAO/T-HEHS-95-67, January 27, 1995, 3.
130. GAO, New Functional Assessments, 9–10.
131. J. Perrin, K. Kuhlthau, T. MacLaughlin, S. Ettner, and S. Gortmaker, “Changing Patterns of Conditions among Children Receiving Supplemental Security Income Disability benefits,” Archives of Pediatric and Adolescent Medicine 153 (1999): 80-84.
132. See J Currie and J. Gruber, “Health Insurance Eligibility, Utilization of Medical Care, and Child Health,” Quarterly Journal of Economics 111 (May 1996): 431-66.
133. See L. Dubay and G. Kenney, “The Effects of Medicaid Expansions on Insurance Coverage of Children,” Special Education for Children with Disabilities 6 (Spring 1996): 152-61.
134. Erkulwater, Disability Rights and the American Social Safety Net, 158–59.
135. D. Morgan, “Medicaid Costs Balloon into a Fiscal ‘Time Bomb,’” Washington Post, 30 January 1994, A1
136. R. Lombardi, “The Evaluation of Children's Impairments in Determining Disability under the Supplemental Security Income Program,” Fordham Law Review 57 (1989): 1107.
137. F. Ullman, I. Hill, and R. Almeida, “CHIP: A Look at Emerging State Programs,” New Federalism: Issues and Options for States, Urban Institute, Series A, No. A-35, September 1999.
138. A. Cuellar and S. Markowitz, “Medicaid Policy Changes in Mental Health Care and Their Effect on Mental Health Outcomes,” Health Economics, Policy, and Law 2 (2007): 23.
139. J. Zito, D. Safer, S. doesReis, J. Gardner, L. Magder, and K. Soeken et al. “ Psycho tropic Practice Patterns for Youth,” Archives of Pediatrics & Adolescent Medicine 157 (January 2003): 17-25.
140. See L. Sax and K. Kautz, “Who First Suggests the Diagnosis of Attention-Deficit/ Hyperactivity Disorder?” Annals of Family Medicine 1 (September-October 2003): 171-74.
141. See G. DuPaul, G. Stoner, ADHD in Schools: Assessment and Intervention Strategies (New York, 2003)
142. M. Stein, N. Marx, J. Beard, M. Lerner, B. Levin, and F. Glascoe et al. “adhd: The Diagnostic Process from Different Perspectives,” Journal of Developmental and Behavioral Pediatrics 25 (February 2004): 53-58
143. J. Biederman, S. Faraone, M. Monuteaux, and J. Grossbard, “How Informative Are Parent Reports of Attention-Deficit/ Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long- Acting Treatments? A Pooled Analysis of Parents' and Teachers' Reports,” Pediatrics 113 (June 2004): 1667-71
144. J. Biederman, H. Gao, A. Rogers, and T. Spencer, “Comparison of Parent and Teacher Reports of Attention-Deficit/Hyperactivity Disorder Symptoms from Two Placebo-Controlled Studies of Atomoxetine in Children,” Biological Psychiatry 60 (15 November 2006): 1106–10.
145. J. Havey, J. Olson, C. McCormick, and G. Cates, “Teachers' Perceptions of the Incidence and Management of Attention-Deficit Hyperactivity Disorder,” Applied Neuropsychology 12 (2005): 120-27.
146. See S. Hinshaw and D. Cicchetti, “Stigma and Mental Disorder: Conceptions of Illness, Public Attitudes, Personal Disclosure, and Social Policy,” Development and Psychopathology 12 (2000): 555-98
147. L. Diller, “The Run on Ritalin: Attention Deficit Disorder and Stimulant Treatment in the 1990s,” Hastings Center Report 26 (March-April 1996): 12-18.
148. See P. Conrad and D. Potter, “From Hyperactive Children to adhd Adults: Observations on the Expansion of Medical Categories,” Social Problems 47 (2000): 559-82.
149. G. Cowley, “The Promise of Prozac,” Newsweek, 26 March 1990.
150. See S. Mintz, Huck's Raft : A History of American Childhood (Cambridge, MasS. 2004).
151. Diller, “The Run on Ritalin,” 17.
152. See S. Timimi, “adhd Is Best Understood as a Cultural Construct,” British Journal of Psychiatry 184 (2004): 8-9
153. P. Conrad, “The Shift ing Engines of Medicalization,” Journal of Health and Social Behavior 46 (March 2005): 3-14
154. P. Conrad and V. Leiter, “Medicalizatoin, Markets, and Consumers,” Journal of Health and Social Behavior 45 (2004): 158-76.
155. See S. Hinshaw and D. Cicchetti, “Stigma and Mental Disorders: Conceptions of Illness, Public Attitudes, Personal Disclosure, and Social Policy,” Development and Psychopathology 12 (2000): 574.
156. See R. Bussing, N. Schoenberg, and A. Perwien, “Knowledge and Information about adhd: Evidence of Cultural Differences among African-American and White Parents,” Social Science & Medicine 46 (April 1998): 919-28
157. J. McLeod, D. Fettes, P. Jensen, B. Pescosolido, and J. Martin, “Public Knowledge, Beliefs, and Treatment Preferences Concerning Attention-Deficit Hyperactivity Disorder,” Psychiatric Services 58 (May 2007): 626-31.
158. B. Good, “Studying Mental Illness in Context: Local, Global, or Universal?” Ethos 25 (1997): 231.
159. See P. Breggin, Talking Back to Ritalin (New York, 2001).
160. For more on the inherent subjectivity and clinical uncertainty in diagnosing and treating mental disorders, see T. Luhrmann, Of Two Minds: The Growing Disorder in American Psychiatry (New York, 2001).
161. See T. Power, T. Costigan, S. Leff, R. Eiraldi, and S. Landau, “Assessing adhd Across Settings: Contributions of Behavioral Assessment to Categorical Decision-Making,” Journal of Clinical Child Psychology 30 (September 2001): 399-412.
162. See I. Singh, “A Framework for Understanding Trends in adhd Diagnosis and Stimulant Drug Treatment: School and Schooling as a Case Study,” BioSocieties 1 (2006): 439-52.